Literature DB >> 26216785

Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.

Laura Ordoñez-Boschetti1, Roberto Rey, Ana Cruz, Arijit Sinha, Tracy Reynolds, Nadina Frider, Regina Alvarenga.   

Abstract

Entities:  

Year:  2015        PMID: 26216785      PMCID: PMC4522032          DOI: 10.1007/s12325-015-0230-4

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


× No keyword cloud information.
  1 in total

1.  Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.

Authors:  Ralf A Linker; Guillaume Wendt
Journal:  Neurol Ther       Date:  2016-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.